Chondrosarcoma

subtype

Identifier: CI-CAN-00000757
Entity page: /cancer/chondrosarcoma ↗
Edges: 124

Neighbours: 2 genes2 variants21 drugs10 trials
Drawn: 35 of 35 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Chondrosarcoma prognostic in …PROGNOSTIC_IN2 of 2
← prognostic in	IDH2 Mutationother	supports	B	Chondrosarcoma	1	Curated	civic	graph →
← prognostic in	IDH1 Mutationother	supports	B

Chondrosarcoma associated with …ASSOCIATED_WITH2 of 2
← associated with	IDH2	supports	B	Chondrosarcoma	1	Curated	civic	graph →
← associated with	IDH1	supports	B	Chondrosarcoma	1	Curated	civic	graph →

Chondrosarcoma associated with …ASSOCIATED_WITH2 of 2

← associated with

IDH2

supports

Chondrosarcoma

Curated

Chondrosarcoma investigated for …INVESTIGATED_FOR8 of 8
← investigated for	Pazopanibsmall_molecule	unknown	2	Chondrosarcoma	1	Curated	chembl	graph →
← investigated for	Patidegibsmall_molecule	unknown	2	Chondrosarcoma	1	Curated	chembl	graph →
← investigated for	Ivosidenibsmall_molecule	unknown	2	Chondrosarcoma	1	Curated	chembl	graph →
← investigated for	Imatinib Mesylatesmall_molecule	unknown	2	Chondrosarcoma	1	Curated	chembl	graph →
← investigated for	Imatinibsmall_molecule	unknown	2	Chondrosarcoma	1	Curated	chembl	graph →
← investigated for	Everolimussmall_molecule	unknown	2	Chondrosarcoma	1	Curated	chembl	graph →
← investigated for	Zoledronic Acidsmall_molecule	unknown	1	Chondrosarcoma	1	Curated	chembl	graph →
← investigated for	Tanespimycinsmall_molecule	unknown	1	Chondrosarcoma	1	Curated	chembl	graph →

Chondrosarcoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 39show all (up to 200)
→ investigated in trials for	Pazopanibsmall_molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Ifosfamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Enasidenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ivosidenibsmall_molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →

Chondrosarcoma studied in …STUDIED_INderived10 of 73show all (up to 200)
→ studied in	NCT00496522Phase 2 · active not recruiting Proton Beam Therapy for Chondrosarcoma · condition mapped ONTOLOGY_EXACT · 73 trials mapped (30 active)	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 73 trials mapped (30 active)	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01267955Phase 2 · active not recruiting Vismodegib in Treating Patients With Advanced Chondrosarcomas · condition mapped CURATED_BROADER · 73 trials mapped (30 active)	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 73 trials mapped (30 active)	—	—	Extraskeletal Myxoid Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04458922Phase 2 · active not recruiting Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma · condition mapped ONTOLOGY_EXACT · 73 trials mapped (30 active)	—	—	Central Chondrosarcoma, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT07734805active not recruiting Radiological Diagnosis of Pediatric Neck Swellings · condition mapped ONTOLOGY_EXACT · 73 trials mapped (30 active)	—	—	Myxoid Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04040205Phase 2 · recruiting Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration · condition mapped ONTOLOGY_EXACT · 73 trials mapped (30 active)	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04521686Phase 1 · active not recruiting Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations · condition mapped ONTOLOGY_EXACT · 73 trials mapped (30 active)	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02389244Phase 2 · completed A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas · condition mapped ALIAS · 73 trials mapped (30 active)	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 73 trials mapped (30 active)	—	—	Chondrosarcoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains